Ergot Alkaloids and Related Compounds

Citations of this article
Mendeley users who have this article in their library.
Get full text


I Introduction to the Pharmacology of Ergot Alkaloids and Related Compounds as a Basis of Their Therapeutic Application -- II Chemical Background -- A. Occurrence, Biosynthesis, and Production -- B. Structure and Synthesis of the Natural Alkaloids -- C. Chemical Modifications in the Lysergic Acid Half of Ergot Alkaloids -- D. Chemical Modification in the Peptide Part of Ergot Alkaloids -- E. Some Analytical Tools for the Determination of Ergot Alkaloids -- F. Subject Index -- G. References -- III Basic Pharmacological Properties -- A. Introduction -- B. Actions of Ergot Alkaloids at 5-HT Receptors -- C. Actions of Ergot Alkaloids at Dopamine Receptors -- D. Actions of Ergot Alkaloids at Adrenoceptors -- E. The Shape of Ergotamine and Dihydroergotamine in Relation to Their Interaction With?-Adrenoceptors -- F. Actions of Ergot Alkaloids at Acetylcholine Receptors -- G. Actions of Ergot Alkaloids at Histamine Receptors -- H. Interaction of Ergot Alkaloids With Prostaglandins -- J. Stimulation of Smooth Muscle by Ergot Alkaloids Mediated by Miscellaneous Mechanisms -- K. Biochemical Identification of Specific Binding Sites for Ergot Alkaloids -- L. References -- IV Effects on the Uterus -- A. Introduction -- B. Actions on Uterine Motor Activity -- C. References -- V Actions on the Heart and Circulation -- A. Actions on Systemic Blood Pressure -- B. Hemodynamic Effects -- C. Effects on Regional Hemodynamics -- D. Actions on the Heart -- E. Pharmacologic Basis for the Clinical Use of Ergot Alkaloids -- F. References -- VI Effects on the Central Nervous System -- A. Introduction -- B. Early Evidence of Central Effects -- C. Whole-Animal Studies -- D. Synaptic Transmission: Catecholaminergic Mechanisms -- E. Synaptic Transmission: Serotoninergic Mechanisms -- F. Brain Metabolism -- G. References -- VII Clinical Pharmacology of Ergot Alkaloids in Senile Cerebral Insufficiency -- A. Introduction -- B. Terminology, Etiology, and Pathology of the Aging Process of the Brain -- C. Research Techniques Used in Clinical Pharmacologic Studies of Ergot Alkaloids in Senile Cerebral Insufficiency -- D. Results of Clinical Pharmacology Studies With Ergot Alkaloids -- E. Summary -- F. References -- VIII Some Compounds With Hallucinogenic Activity -- A. Introduction -- B. Discovery of LSD -- C. Effects of LSD in Man -- D. Clinical Applications of LSD -- E. LSD Analogues Tested in Man -- F. Cross-Tolerance -- G. References -- IX Influence on the Endocrine System -- A. Animal Data -- B. Human Data -- C. References -- X Metabolic Effects -- A. Introduction -- B. In Vitro Systems -- C. Intact Animals and Men -- D. Various Actions of Ergot Alkaloids -- E. References -- XI Biopharmaceutical Aspects. Analytical Methods, Pharmacokinetics, Metabolism and Bioavailability -- A. Introduction -- B. Assay of Ergot Alkaloids -- C. Pharmacokinetics -- D. Metabolism -- E. References -- XII Toxicologic Considerations -- A. Introduction -- B. Systemic Toxicity -- C. Effects on Reproductive Processes -- D. Potential Genetic Effects -- E. Interactions Leading to Enhanced Toxicity -- F. Summary -- G. References -- Authors Index.




Ergot Alkaloids and Related Compounds. (1978). Ergot Alkaloids and Related Compounds. Springer Berlin Heidelberg.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free